ABX203

Abivax May List on Nasdaq After U.S. Lifts Cuba Embargo
Bloomberg
Thu, 07/2/15 - 11:22 am
Abivax
France
NASDAQ
vaccines
Cuba
ABX203
hepatitis B
Abivax tees up a $49M IPO to get its hep B shot into Phase III
Fierce Biotech
Fri, 06/5/15 - 10:38 am
Abivax
IPOs
hepatitis B
vaccines
ABX203
Europe